These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 23494860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
    Meixner CN, Aref MW, Gupta A, McNerny EMB, Brown D, Wallace JM, Allen MR.
    Calcif Tissue Int; 2017 Jul; 101(1):75-81. PubMed ID: 28246928
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness.
    Luo TD, Allen MR.
    Bone; 2013 Sep; 56(1):199-203. PubMed ID: 23774445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite.
    Suratwala SJ, Cho SK, van Raalte JJ, Park SH, Seo SW, Chang SS, Gardner TR, Lee FY.
    J Bone Joint Surg Am; 2008 Oct; 90(10):2189-96. PubMed ID: 18829917
    [Abstract] [Full Text] [Related]

  • 7. Zoledronate reduces unwanted bone resorption in intercalary bone allografts.
    Seo SW, Cho SK, Storer SK, Lee FY.
    Int Orthop; 2010 Apr; 34(4):599-603. PubMed ID: 19343345
    [Abstract] [Full Text] [Related]

  • 8. Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study.
    Stadelmann VA, Gauthier O, Terrier A, Bouler JM, Pioletti DP.
    Eur Cell Mater; 2008 Jul 31; 16():10-6. PubMed ID: 18671203
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing.
    Hao Y, Wang X, Wang L, Lu Y, Mao Z, Ge S, Dai K.
    Bone; 2015 Dec 31; 81():702-711. PubMed ID: 26434668
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High concentrations of pamidronate in bone weaken the mechanical properties of intact femora in a rat model.
    Yang KH, Won JH, Yoon HK, Ryu JH, Choo KS, Kim JS.
    Yonsei Med J; 2007 Aug 31; 48(4):653-8. PubMed ID: 17722238
    [Abstract] [Full Text] [Related]

  • 14. Recent Advances in Understanding Bisphosphonate Effects on Bone Mechanical Properties.
    Allen MR.
    Curr Osteoporos Rep; 2018 Apr 31; 16(2):198-204. PubMed ID: 29497927
    [Abstract] [Full Text] [Related]

  • 15. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
    Amanat N, McDonald M, Godfrey C, Bilston L, Little D.
    J Bone Miner Res; 2007 Jun 31; 22(6):867-76. PubMed ID: 17371160
    [Abstract] [Full Text] [Related]

  • 16. Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.
    Allen MR, Burr DB.
    Osteoporos Int; 2008 Jan 31; 19(1):95-9. PubMed ID: 17710353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.